Pilot a monitored adherence support using FLOW technology linking with social media/WeChat for DS-TB patients in remote Tibet. Dosing history recorded by FLOW will present in WeChat and link to NTP. Patients at high risk to loss-to-follow-up will be invited for VOT via WeChat.